SILO · Silo Pharma, Inc. · Investor Relations
$1.20
+0.07 (+6.19%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 13, 2026
The latest filing states the doubt was alleviated.
“The positive working capital and the July 2026 Private Placement (see Note 9) serve to mitigate the conditions that historically raised substantial doubt about the Company’s ability to continue as a going concern. The Company believes that it has sufficient cash and liquid short-term investments to meet its obligations for a minimum of twelve months from the date of this filing.”View the 10-Q filed Aug 13, 2026
Market Cap
$1.79M
Shares
1.59M
Volume · Oct 20
9514
Avg daily vol (3M)
96.16K
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2024-09-09 | H.C. Wainwright 26th Annual Global Investment Conference | Conference |
Source: https://ir.silopharma.com/